Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
AFT Pharmaceuticals Ltd. (AU:AFP)
ASX:AFP
RESEARCH TOOLSreports
AFT Pharmaceuticals Ltd. (AFP) Share Price & Analysis
3 Followers
AFP Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$2.43 - AU$3.90
Previous CloseAU$2.93
Volume0.00
Average Volume (3M)3.83K
Market Cap
AU$282.86M
Enterprise ValueAU$312.17M
Total Cash (Recent Filing)$7.94M
Total Debt (Recent Filing)$40.51M
Price to Earnings (P/E)21.2
Beta-0.31
Next Earnings
Nov 21, 2024EPS EstimateN/A
Last Dividend Ex-Date
Jun 19, 2024Dividend Yield0.51%
Share Statistics
EPS (TTM)0.14
Shares Outstanding104,866,260
10 Day Avg. Volume34,422
30 Day Avg. Volume3,834
Standard Deviation0.10
R-Squared0.06
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
AFT Pharmaceuticals Ltd. News
PremiumCompany Announcements
AFT Pharmaceuticals Expands into China with Crystaderm
PremiumCompany Announcements
AFT Pharmaceuticals’ Shareholder Meeting Details
PremiumCompany Announcements
AFT Pharmaceuticals Updates Dividend Details
PremiumCompany Announcements
AFT Pharmaceuticals Expands U.S. Presence with Alexso
PremiumCompany Announcements
AFT Pharmaceuticals Declares Upcoming Dividend
PremiumCompany Announcements
AFT Pharmaceuticals Unveils Annual Financial OverviewPremiumCompany Announcements
AFT Pharmaceuticals Celebrates Record EarningsOptions Prices
Currently, No data available
---
Ownership Overview
70.33% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
29.67% Public Companies and
Individual Investors
AFP FAQ
What was AFT Pharmaceuticals Ltd.’s price range in the past 12 months?
AFT Pharmaceuticals Ltd. lowest share price was AU$2.43 and its highest was AU$3.90 in the past 12 months.
What is AFT Pharmaceuticals Ltd.’s market cap?
Currently, no data Available
When is AFT Pharmaceuticals Ltd.’s upcoming earnings report date?
AFT Pharmaceuticals Ltd.’s upcoming earnings report date is Nov 21, 2024 which is in 118 days.
How were AFT Pharmaceuticals Ltd.’s earnings last quarter?
AFT Pharmaceuticals Ltd. released its earnings results on May 23, 2024. The company reported AU$0.122 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.122.
Is AFT Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts AFT Pharmaceuticals Ltd.’s price is currently Overvalued.
Does AFT Pharmaceuticals Ltd. pay dividends?
AFT Pharmaceuticals Ltd. pays a Annually dividend of AU$0.01 which represents an annual dividend yield of 0.51%. See more information on AFT Pharmaceuticals Ltd. dividends here
What is AFT Pharmaceuticals Ltd.’s EPS estimate?
AFT Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AFT Pharmaceuticals Ltd. have?
AFT Pharmaceuticals Ltd. has 104,866,260 shares outstanding.
What happened to AFT Pharmaceuticals Ltd.’s price movement after its last earnings report?
AFT Pharmaceuticals Ltd. reported an EPS of AU$0.122 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of AFT Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in AU:AFP
---
AFT Pharmaceuticals Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.36%
12-Months-Change
Fundamentals
Return on Equity
19.47%
Trailing 12-Months
Asset Growth
9.54%
Trailing 12-Months
Company Description
AFT Pharmaceuticals Ltd.
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Coco-scalp, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Southeast Asia and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.
---
AFP Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Sonic Healthcare Limited
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Althea Group Holdings Ltd.
―
---